Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma

Table 5

Correlations between PD-L1/PD-1 coexpression with CXCR3/CD36, IL-19, and different sites of extranodal involvement in lymphoma. Post-T: posttherapy; CNS: the central nervous system. identifies significant differences at ; identifies high significant differences at .

	Post-T IL-19		Post-T CXCR3%		Post-T PDL-1 + CXCR3 + %		Post-T PD-1 + CXCR3 + %		Post-T CD36%		Post-T PD-L1 + CD36 + %		Post-T PD-1 + CD36 + %
		value		value		value		value		value		value		value
Metastasis	0.848	<0.001	0.771	<0.001	0.793	<0.001	0.528	<0.001	-0.792	<0.001	0.333	0.003	0.469	<0.001
CNS	0.023	0.843	0.149	0.192	0.175	0.126	0.048	0.674	-0.119	0.299	0.081	0.480	0.093	0.420
Bone marrow	0.637	<0.001	0.645	<0.001	0.676	<0.001	0.369	0.001	-0.633	<0.001	0.312	0.005	0.390	<0.001
Lymph vessels	0.437	<0.001	0.499	<0.001	0.487	<0.001	0.272	0.016	-0.386	<0.001	0.144	0.210	0.144	0.210
Intestine	-0.139	0.224	-0.142	0.216	-0.190	0.095	-0.150	0.189	0.167	0.144	-0.180	0.115	-0.195	0.086
Lung	0.278	0.014	0.277	0.014	0.286	0.011	0.235	0.038	-0.205	0.071	0.141	0.219	0.234	0.040
Liver	0.143	0.210	0.118	0.305	0.080	0.487	0.176	0.124	-0.071	0.538	0.129	0.262	0.111	0.332
Thyroid	0.165	0.150	0.160	0.163	0.188	0.100	0.048	0.674	-0.114	0.321	0.104	0.366	0.136	0.234
Spleen	0.124	0.280	0.103	0.368	0.148	0.197	0.043	0.711	-0.327	0.004	0.023	0.838	0.111	0.335